65 results on '"Pirisi, Mario"'
Search Results
2. The association between education level and chronic liver disease of any etiology
3. Eosinophilic gastroenteritis in pregnancy: A review of the literature
4. Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology
5. FRI-028 Spleen stiffness measurement improves non-invasive prediction of clinically significant portal hypertension in patients with compensated advanced chronic liver disease of mixed etiology
6. THU-486-YI A multi-center comparison of Atezolizumab plus Bevacizumab and Lenvatinib as primary systemic therapy for unresectable hepatocellar carcinoma: focus on thrombotic and hemorragic adverse events
7. THU-471-YI From randomised clinical trials to clinical practice: a systematic reviewand meta-analysis of real-word data on atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
8. SAT-524 Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study
9. THU-153 Spleen stiffness measurement improves non-invasive prediction of clinically significant portal hypertension in primary biliary cholangitis
10. OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
11. A nurse-led coaching intervention with home telemonitoring for patients with heart failure: Protocol for a feasibility randomized clinical trial
12. THU-156 - Tolerability of first line systemic therapy in elderly patients with advanced hepatocellular carcinoma
13. THU-134 - Feasibility of systemic anti-cancer therapy as an alternative to best supportive care in patients with advanced HCC and Child-Pugh B liver dysfunction
14. WED-284 - Spleen stiffness measurement predicts decompensation risk in primary biliary cholangitis
15. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients
16. SAT583 - Potential role of soluble triggering receptor expressed on myeloid cells 2 in risk stratification of patients with hepatocellular carcinoma
17. SAT582 - Genes modulating liver fat accumulation and lipogenesis predict development of hepatocellular carcinoma among direct antiviral agents treated cirrhotics C with and without viral clearance
18. Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation
19. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study.
20. Serum iron indices as a measure of iron deposits in chronic hepatitis C
21. HepaDisk – A new quality of life questionnaire for HCV patients.
22. THU-187-Objective evidence of neurocognitive impairment associated with hepatitis C virus infection and of its regression after viral clearance with direct antivirals
23. PS-113-Analysis of the HSD17B13: TA allelic variant as a putative protective factor towards hepatocellular carcinoma in patients with and without chronic hepatitis C
24. Cerebral nervous system vasculitis in a Covid-19 patient with pneumonia.
25. A rare cause of intractable diarrhea
26. Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma.
27. Hepatitis B virus and lymphomagenesis: Novel insights into an occult relationship.
28. Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study.
29. An unusual adverse reaction to iodine-based contrast agent.
30. Evaluation of Serum Levels of Osteopontin and IgG Anti-Osteopontin Autoantibodies As Potential Biomarkers of Immune Activation in Patients with Allergic Diseases.
31. Gene polymorphism at the interleukin 6 -174 G>C locus affects the outcome of chronic hepatitis B.
32. Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification.
33. Efficacy Among North American and European HCV Genotype-1 Treatment-NaïVE and Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin.
34. Thrombocytopenia of chronic liver disease corrected by erythropoietin treatment
35. High prevalence of infection with hepatitis C virus in patients with hepatic and extrahepatic malignancies
36. Blood lipids of patients with chronic hepatitis: differences related to viral etiology
37. Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules
38. Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter.
39. Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma.
40. Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.
41. B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).
42. Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology.
43. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.
44. Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms?
45. Role of beta-blockers in patients with COPD: current perspective.
46. Impaired glucose metabolism in hypertensive patients with/without the metabolic syndrome.
47. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC
48. Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C
49. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: The role of AST to the platelet ratio index
50. Thrombocytopenia of chronic liver disease corrected by erythropoietin treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.